This Viewpoint explores whether there are benefits to drugs targeting β-amyloid protein in treating Alzheimer disease.
No takes yet. Share an insight, caveat, or question.
Molchan et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: